Search research articles
Contact Us
Filters
Showing results (21-30 of 42) with videos related to
Page
of 5
Sort By:
Critical Reviews in Oncology/Hematology
|
June 18, 2011
Disseminated and circulating tumor cells in gastrointestinal oncology
F C Bidard, F R Ferrand, F Huguet, et al.
ESMO Open
|
March 5, 2026
Imlunestrant plus abemaciclib versus fulvestrant plus abemaciclib in ER-positive, HER2-negative advanced breast cancer: an indirect treatment comparison of three phase III trials
K Jhaveri, F C Bidard, K Kalinsky, et al.
ESMO Open
|
September 4, 2024
Elacestrant in ESR1-mutant, endocrine-responsive metastatic breast cancer: should health authorities consider post hoc data to inform priority access?
C Valenza, D Trapani, F-C Bidard, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 2, 2017
Circulating tumor DNA changes for early monitoring of anti-PD1 immunotherapy: a proof-of-concept study
L Cabel, F Riva, V Servois, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 19, 2025
Kinetics and determinants of ESR1 mutation detection in metastatic breast cancer
L Cabel, F Berger, T Bachelot, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 10, 2013
Circulating tumor cells and brain metastasis outcome in patients with HER2-positive breast cancer: the LANDSCAPE trial
J-Y Pierga, F-C Bidard, C Cropet, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 9, 2015
Response to dual HER2 blockade in a patient with HER3-mutant metastatic breast cancer
F-C Bidard, C K Y Ng, P Cottu, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 11, 2014
Capturing intra-tumor genetic heterogeneity by de novo mutation profiling of circulating cell-free tumor DNA: a proof-of-principle
L De Mattos-Arruda, B Weigelt, J Cortes, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 9, 2022
ESMO recommendations on the use of circulating tumour DNA assays for patients with cancer: a report from the ESMO Precision Medicine Working Group
J Pascual, G Attard, F-C Bidard, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 8, 2016
A phase II trial of abiraterone acetate plus prednisone in patients with triple-negative androgen receptor positive locally advanced or metastatic breast cancer (UCBG 12-1)
H Bonnefoi, T Grellety, O Tredan, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 42) with videos related to
Sort By:
Page
of 5
Critical Reviews in Oncology/Hematology
|
June 18, 2011
Disseminated and circulating tumor cells in gastrointestinal oncology
F C Bidard, F R Ferrand, F Huguet, et al.
ESMO Open
|
March 5, 2026
Imlunestrant plus abemaciclib versus fulvestrant plus abemaciclib in ER-positive, HER2-negative advanced breast cancer: an indirect treatment comparison of three phase III trials
K Jhaveri, F C Bidard, K Kalinsky, et al.
ESMO Open
|
September 4, 2024
Elacestrant in ESR1-mutant, endocrine-responsive metastatic breast cancer: should health authorities consider post hoc data to inform priority access?
C Valenza, D Trapani, F-C Bidard, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 2, 2017
Circulating tumor DNA changes for early monitoring of anti-PD1 immunotherapy: a proof-of-concept study
L Cabel, F Riva, V Servois, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 19, 2025
Kinetics and determinants of ESR1 mutation detection in metastatic breast cancer
L Cabel, F Berger, T Bachelot, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 10, 2013
Circulating tumor cells and brain metastasis outcome in patients with HER2-positive breast cancer: the LANDSCAPE trial
J-Y Pierga, F-C Bidard, C Cropet, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 9, 2015
Response to dual HER2 blockade in a patient with HER3-mutant metastatic breast cancer
F-C Bidard, C K Y Ng, P Cottu, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 11, 2014
Capturing intra-tumor genetic heterogeneity by de novo mutation profiling of circulating cell-free tumor DNA: a proof-of-principle
L De Mattos-Arruda, B Weigelt, J Cortes, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 9, 2022
ESMO recommendations on the use of circulating tumour DNA assays for patients with cancer: a report from the ESMO Precision Medicine Working Group
J Pascual, G Attard, F-C Bidard, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 8, 2016
A phase II trial of abiraterone acetate plus prednisone in patients with triple-negative androgen receptor positive locally advanced or metastatic breast cancer (UCBG 12-1)
H Bonnefoi, T Grellety, O Tredan, et al.
Page
of 5